Buprenorphine Market Segmentation, Global Demand Analysis, and Opportunity Outlook

Buprenorphine Market
Buprenorphine Market

An opioid called buprenorphine is used to treat both acute and chronic pain as well as opioid use disorder. It can be injected (intravenous and subcutaneous), applied as a patch on the skin (transdermal), placed under the tongue (sublingual), in the cheek (buccal), or used as an implant. The distribution channel and method of administration are used to segment the global buprenorphine market. Due to the increasing accessibility of buprenorphine medications in oral dose form, the sublingual route of administration is predicted to capture the greatest market share throughout the projection period. Furthermore, due to the rising popularity of oral medications, the buccal category is anticipated to experience the highest market growth in the coming years. The first two days of treatment for opioid use disorder are typically spent under the watchful supervision of a healthcare provider after withdrawal symptoms start to manifest.

The global Buprenorphine Market is estimated to be valued at US$ 3,681.9 million in 2020 and is expected to exhibit a CAGR of 14.5% during the forecast period (2020-2027).

Suboxone, a buprenorphine/naloxone combination medication, is frequently used in the US to stop the abuse of injectable drugs. Maximum pain relief is often attained in an hour, and effects can last up to 24 hours. Buprenorphine has a variety of effects on various opioid receptor types. Depending on the kind of receptor, it might be an agonist, partial agonist, or antagonist.

A wide variety of serious chronic diseases affect the general population, including cancer, pain brought on by injuries, and other ailments. This is causing people to use painkillers more frequently. The likelihood of developing a drug addiction rises as the pain subsides. As a result, it is predicted that buprenorphine's demand as an anti-opioid medicine would increase. An opioid called buprenorphine is prescribed to individuals with multiple sclerosis, cancer, or other life-threatening illnesses to manage both acute and chronic pain. Additionally, it is anticipated that the increased incidence of cancer would increase demand for cancer treatments, which will fuel the expansion of the worldwide buprenorphine market. For instance, a million people were given a cancer diagnosis in 2018, according to a factsheet from Cancer Research UK.

 

Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries